List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 13 studies with search of:   "Miltefosine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
Condition: Treatment of Cutaneous Leishmaniasis in Brazil.
Interventions: Drug: Miltefosine.;   Drug: Meglumine antimoniate.;   Drug: Miltefosine.;   Drug: Meglumine antimoniate.
2 Recruiting Combination Therapy in Indian Visceral Leishmaniasis
Condition: Leishmaniasis, Visceral
Interventions: Drug: amphotericin B deoxycholate;   Drug: Liposomal Amphotericin B with Miltefosine;   Drug: Liposomal Amphotericin B and Paromomycin Sulfate;   Drug: miltefosine + Paromomycin sulfate
3 Recruiting Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B Deoxycholate;   Drug: Ambisome + Miltefosine;   Drug: Ambisome and Paromomycin;   Drug: Miltefosine and Paromomycin
4 Active, not recruiting Efficacy and Safety Study of Miltefosine for Cutaneous Leishmaniasis in Colombia
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
5 Recruiting Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B and Miltefosine
6 Active, not recruiting Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
Condition: Cutaneous Leishmaniasis
Interventions: Drug: miltefosine;   Drug: antimony
7 Recruiting Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
Condition: Cutaneous Leishmaniasis
Interventions: Drug: miltefosine;   Drug: meglumine antimoniate
8 Active, not recruiting Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: miltefosine: 2.5 mg/kg/day for 42 days
9 Recruiting Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
Condition: Cutaneous Leihmaniasis
Intervention: Drug: Miltefosine , meglumine antimoniate
10 Completed Miltefosine for Mucosal Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: miltefosine 2.5 mg/kg/day for 28 days
11 Recruiting Miltefosine for Brazilian Visceral Leishmaniasis
Condition: Kala Azar
Intervention: Drug: Miltefosine: initially 2.5 mg/kg/day for 28 days
12 Completed Combination Chemotherapy for the Treatment of Indian Kala-Azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Combination therapy with AmBisome and miltefosine
13 Completed Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefose

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services